SlideShare une entreprise Scribd logo
1  sur  45
JOURNAL REVIEW 
KIDNEY PRESERVATION: 
METHODS AND TRENDS 
Keith Tsui, Daniel Wong, Kenneth Kwok, Patrick Tsai, Bernard Yung
Outline 
• History of kidney preservation 
• Static Cold Storage (SCS) 
• Hypothermic Machine Perfusion (HMP) 
• SCS vs HMC 
• Conclusion
Organ transplantation 
• Major advances in latter half of the 20th century 
• Only curative treatment for end-stage organ 
failure in many cases
Deceased Donor Types 
• Donation after brain death (DBD) 
• Standard criteria donors (SCD) 
 Under 50 years old 
• Expanded criteria donors (ECD) 
 Over 60 years old OR 
 Aged 50-59 years old with at least 2 of the following: 
• Hypertension 
• Cerebrovascular cause of brain death 
• Pre-retrieval serum creatinine level > 1.5 mg/dL (132.6umol/L) 
• Donation after circulatory death (DCD) 
Metzger RA, Delmonico FL, Feng S, et al. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003
Kidney transplant 
1. Retrieving the organ from donor 
2. Preserving the kidney 
3. Implantation in the recipient
Why organ preservation? 
 Preservation buys “time” 
 Good organ preservation is a major 
determinant of graft outcome after 
re-vascularisation 
Organ Preservation: Current Concepts and New Strategies for the Next Decade; 
Transfus Med Hemother. Apr 2011
Methods of Organ Preservation 
• Static Cold Storage (SCS) 
• Dynamic Preservation 
• Hypothermic machine perfusion (HMP) 
• Normothermic machine perfusion 
• Oxygen persufflation
KIDNEY 
PRESERVATION 
Static Cold Storage
Kidney Preservation 
Warm 
ischaemic time 
in donor 
Cold 
ischaemic time 
Warm 
ischaemic time 
in recipient
Static Cold Storage (SCS) 
• First used in 1969, with Collins solution 
• Mainstay method of preservation for kidneys, 
livers, and others 
• Tackle problems during cold ischaemic time 
preservation possible up to 24 hours or longer 
“Preservation Solutions for Static Cold Storage of Kidney Allografts: A Systematic Review 
and Meta-Analysis”, American Journal of Transplantation 2012
Static Cold Storage (SCS) 
•Wash with sterile hypothermic preservation 
solution 
• Kidney core temperature  0-4oC 
• Store in ice water 
Image source: St. Louis Public Radio
In ischaemic condition… 
No Oxygen 
Intracellular ATP depletion 
Impaired Na/K ATPase 
Passive inflow of Na 
Water influx 
Cell swelling and 
damage 
Anaerobic respiration 
Lactic acid builds up 
Activate intracellular enzymes 
Lysosomal damage 
Na/Ca exchange 
Build up of 
intracellular Ca 
“Kidney Preservation: Review of Present and Future Perspective”, Transplantation Proceedings 2013
Principles used in SCS 
1. Hypothermia decrease kinetics of metabolic 
activities 
2. Specific solutions preserve intracellular 
environment in the absence of Na+/K+ pumps 
3. High osmolarity in solutions reduce cell 
swelling 
4. Remove free radicals 
“Preservation methods for kidney and liver”, Organogenesis 2009
Advantages of SCS 
• Cheaper 
- 1L UW solution: 
£116 (~HKD$1500) 
- LifePort kidney transporter x1: 
£10,700 (~HKD$135,000) 
+ other costs 
Nice Guideline 2010 
• Technically easier
Disadvantages of SCS 
• No standardised parameters to evaluate: 
1. organ viability 
2. ischaemic damage 
 predictors of post-transplant outcomes
KIDNEY 
PRESERVATION 
The Solutions
EC, Eurocollins 
UW, University of Wisconsin 
HTK, histidine-tryptophan-ketoglutarate;
Euro-Collins solution 
•Phosphate - as pH buffer 
•Glucose - as osmotic agent 
Preservation methods for kidney and liver; Organogenesis. 2009
EC, Eurocollins 
UW, University of Wisconsin 
HTK, histidine-tryptophan-ketoglutarate;
UW solution 
• Cell impermeant agents (lactobionic acid, 
raffinose, hydroxyethyl starch) 
• prevent the cells from swelling during cold ischemic 
storage 
• Glutathione and adenosine 
• stimulate recovery of normal metabolism upon 
reperfusion 
Organ Preservation; Annual Review of Medicine; Vol. 46
EC, Eurocollins 
UW, University of Wisconsin 
HTK, histidine-tryptophan-ketoglutarate;
Histidine-Tryptophane-Ketoglutarate 
(HTK)** 
• Histidine – as potent buffer 
•Tryptophan – as membrane stabilizer and 
anti-oxidant 
• Ketoglutarate – improve ATP production 
during reperfusion
KIDNEY 
PRESERVATION 
Machine Perfusion
Original method of preservation 
• Replaced by SCS due to 
development of 
preservation solutions as a 
cheaper alternative 
Photo from Kidney Transplant: Principles and Practice
Resurgence of interest 
• Changes in donor pool 
• US 
• ECDs increased 36% between 1999 and 2005 
• 22% of kidneys transplanted in 2009 
• DCD accounted for 13% of donors 
United States Organ Transplantation OPTN & SRTR Annual Data Report 2010 
• UK 
• DCD kidneys in UK increased from 3% to 32% between 
2000 and 2009 
Summers DM, Johnson RJ, Allen J, et al. Analysis of factors that affect outcome after transplantation 
of kidneys donated after cardiac death in the UK: a cohort study. Lancet 2010
Machine Perfusion 
• Solutions 
• Eurocollins solution, UW solution, HTK solution, 
hyperosmolar citrate solution, Celsior solution, Institute 
Georges Lopez-1 solution 
• Hypothermic perfusion 
• Waters MOX DCM-100 
• UP-100 
• LifePort Kidney Transporter 
• Kidney assist 
• Normothermic perfusion 
• POPS system
Basic design of a perfusion machine 
Waters MOX DCM-100
Hypothermic perfusion 
machine 
Normothermic perfusion 
machine
Kidney Preservation: method and trends
Cost effective? 
•LifePort Kidney transporter 
• Cost savings = $86 750 per life-year 
gained 
• Cost utility ratio was minus $496 223 per 
quality-adjusted life-year (QALY) gained 
Cost-Effectiveness of Hypothermic Machine Preservation Versus Static Cold Storage in 
Renal Transplantation; H Groen; American journal of transplantation 2012
Not inferior or even better? 
• No difference in primary non-function, acute 
rejection, long-term renal function or patient 
survival 
Systematic review and meta-analysis of hypothermic machine 
perfusion versus static cold storage of kidney allografts on 
transplant outcomes; J. M. O’Callaghan; Transplantation 2012 
• Decreased rates of DGF 
To Pump or Not to Pump: A Comparison of Machine 
Perfusion vs Cold Storage for Deceased Donor Kidney 
Transplantation; Robert M Cannon; J Am Coll Surg 2013
Static Cold Storage 
vs 
Hypothermic Machine Perfusion
Study end points 
• Delayed graft function (DGF) 
• Requirement for dialysis during the first week after 
transplantation 
• Primary Non-Function (PNF) 
• Permanent lack of function of allograft from the time of 
transplantation 
• Graft survival/ failure 
• Censored at the time of death
SCS vs HMP 
• International randomized controlled trial with 336 donors
Results 
• Delayed graft function 
• significantly reduced risk of DGF (adjusted odds ratio, 
0.57, p=0.01) 
• Primary Non-Function 
• More than 2 times higher in SCS but not significant 
(4.8% vs 2.1%, p=0.08) 
• Graft survival/ failure 
• Three-year allograft survival superior in MP group (91% 
vs 87%, hazard ratio, 0.60 p=0.04)
ECD Subgroup analysis 
• Expanded criteria donors (94 out of 336) had a 
significant three-year graft survival (86% vs 76%; 
adjusted hazard ratio, 0.38; p=0.01) 
• Another RCT with 91 ECDs had similar results: 
• significantly reduced the risk of DGF (29.7% vs 22%, 
OR 0.460, P = 0.047). 
• incidence of nonfunction in the CS group (12%) was 
four times higher than in the MP group (3%) (P = 0.04). 
• One-year graft survival was significantly higher in 
machine perfused kidneys (92.3% vs. 80.2%, P = 0.02). 
Treckmann J, Moers C, Smits J, et al. Machine perfusion versus cold storage for 
preservation of kidneys from expanded criteria donors after brain death. Transpl Int
Donation after Circulatory Death (DCD) 
• Donors not declared brain death 
• Ethical concerns 
“Hypothermic machine perfusion was associated with a reduced risk of 
DGF and better early graft function up to 1 month after transplantation. 
Routine preservation of DCD kidneys by hypothermic machine 
perfusion is therefore advisable.”
Future of HMP 
• Renal resistance indexes to evaluate marginal 
organs 
Jochmans I, Moers C, Smits J, et al. The prognostic value of renal resistance during 
hypothermic machine perfusion of deceased donor kidneys. Am J Transplant 2011 
• Biomarkers to predict delayed graft function 
Moers C, Varnav OC, van Heurn E, et al. The value of machine perfusion perfusate 
biomarkers for predicting kidney transplant outcome. Transplantation 2010 
• Other methods: normothermic perfusion, oxygen 
persufflation 
Matsuno N, Konno O, Mejit A, et al. Application of machine perfusion preservation as a 
viability test for marginal kidney graft. Transplantation 2006
Take Home Messages 
• Only possible improvement in SCS is new solutions 
• HMP is the way to go? 
• Rapidly advancing field 
• Possible additional benefit of HMP in the future 
• Not inferior to SCS 
• Significant advantage for ECD 
• Look out for other developing methods 
• HMP in other organs?
Special Thanks 
Supervisor: Dr. G Leung 
Acknowledgement: Dr. MK Yiu
UW VS HTK
Which one better? 
Primary end point = Delayed Graft 
Function (DGF)
Which one better? 
Lynch RJ, et al. AJT 2008; 8:567-73
Post-transplant kidney graft survival 
Living Donor: HTK n=475 
UW n=475 
Deceased donor: HTK n=317 
UW n=317 
Lynch RJ, et al. AJT 2008; 8:567-73
Lynch RJ, et al. AJT 2008; 8:567-73

Contenu connexe

Tendances

Dialysis without anticoagulation (Heparin Free Dialysis)
Dialysis without anticoagulation (Heparin Free Dialysis)Dialysis without anticoagulation (Heparin Free Dialysis)
Dialysis without anticoagulation (Heparin Free Dialysis)Mahmoud Eid
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysisReynel Dan
 
Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy Muhammad Asim Rana
 
Approach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGNApproach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGNGarima Aggarwal
 
Transplant in abnormal bladder
Transplant in abnormal bladderTransplant in abnormal bladder
Transplant in abnormal bladderGAURAV NAHAR
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapyaratimohan
 
Renal Replacement Therapy: modes and evidence
Renal Replacement Therapy: modes and evidenceRenal Replacement Therapy: modes and evidence
Renal Replacement Therapy: modes and evidenceMohd Saif Khan
 
Induction agents in renal transplantation
Induction agents in renal transplantationInduction agents in renal transplantation
Induction agents in renal transplantationVishal Golay
 
Hemodialysis anticoagulation
Hemodialysis anticoagulationHemodialysis anticoagulation
Hemodialysis anticoagulationAbdullah Ansari
 
Evaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesEvaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesSunil Kumar Prajapati
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadNephroTube - Dr.Gawad
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of HemodialysisMNDU net
 

Tendances (20)

Deceased donor kidney transplant
Deceased donor kidney transplantDeceased donor kidney transplant
Deceased donor kidney transplant
 
Dialysis without anticoagulation (Heparin Free Dialysis)
Dialysis without anticoagulation (Heparin Free Dialysis)Dialysis without anticoagulation (Heparin Free Dialysis)
Dialysis without anticoagulation (Heparin Free Dialysis)
 
Kidney Donor evaluation
Kidney Donor evaluationKidney Donor evaluation
Kidney Donor evaluation
 
Dialysis prescription
Dialysis prescriptionDialysis prescription
Dialysis prescription
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
 
Crrt in aki
Crrt in akiCrrt in aki
Crrt in aki
 
Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy
 
Approach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGNApproach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGN
 
Metabolic complications in patients ongoing pd
Metabolic complications in patients ongoing pdMetabolic complications in patients ongoing pd
Metabolic complications in patients ongoing pd
 
Transplant in abnormal bladder
Transplant in abnormal bladderTransplant in abnormal bladder
Transplant in abnormal bladder
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
Renal Replacement Therapy: modes and evidence
Renal Replacement Therapy: modes and evidenceRenal Replacement Therapy: modes and evidence
Renal Replacement Therapy: modes and evidence
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
Incremental Dialysis
Incremental DialysisIncremental Dialysis
Incremental Dialysis
 
Continuous Renal Replacement Therapy
Continuous Renal Replacement TherapyContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
 
Induction agents in renal transplantation
Induction agents in renal transplantationInduction agents in renal transplantation
Induction agents in renal transplantation
 
Hemodialysis anticoagulation
Hemodialysis anticoagulationHemodialysis anticoagulation
Hemodialysis anticoagulation
 
Evaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesEvaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidates
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
 

Similaire à Kidney Preservation: method and trends

Renal Replacement therapy in the ICU
Renal Replacement therapy in the ICU Renal Replacement therapy in the ICU
Renal Replacement therapy in the ICU Syed Hussain
 
November2011webinar
November2011webinarNovember2011webinar
November2011webinarthanggmhs
 
Rrt in icu dr said khamis zagazig april 2018 latest
Rrt in  icu dr said khamis zagazig april 2018 latestRrt in  icu dr said khamis zagazig april 2018 latest
Rrt in icu dr said khamis zagazig april 2018 latestFarragBahbah
 
Anesthetic considerations for kidney transplant in an adult
Anesthetic considerations for kidney transplant in an adult Anesthetic considerations for kidney transplant in an adult
Anesthetic considerations for kidney transplant in an adult Eko indra
 
5. perioperative assessment of Hemodialysis patients. Dr. Ahmed Kamal.pptx
5. perioperative assessment of Hemodialysis patients. Dr. Ahmed Kamal.pptx5. perioperative assessment of Hemodialysis patients. Dr. Ahmed Kamal.pptx
5. perioperative assessment of Hemodialysis patients. Dr. Ahmed Kamal.pptxAbdiwahabNoor1
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantationSouvik Maitra
 
Anaesthesia for liver transplantation
Anaesthesia for liver transplantationAnaesthesia for liver transplantation
Anaesthesia for liver transplantationisakakinada
 
Renal transplantation -friday_prof_ayman refaei
Renal transplantation -friday_prof_ayman refaeiRenal transplantation -friday_prof_ayman refaei
Renal transplantation -friday_prof_ayman refaeiFarragBahbah
 
Anaesthesia for renal transplant
Anaesthesia for renal transplantAnaesthesia for renal transplant
Anaesthesia for renal transplantUmang Sharma
 
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdfANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdfSabariKreeshan
 
Prevention of aki on icu
Prevention of aki on icuPrevention of aki on icu
Prevention of aki on icujayhay548
 
Marcelo Cypel - Canada - Tuesday 29 - Organ Donor Care. New Alternatives
Marcelo Cypel  - Canada - Tuesday 29 - Organ Donor Care. New AlternativesMarcelo Cypel  - Canada - Tuesday 29 - Organ Donor Care. New Alternatives
Marcelo Cypel - Canada - Tuesday 29 - Organ Donor Care. New Alternativesincucai_isodp
 
Presentation on Organ Transplantation
Presentation on Organ TransplantationPresentation on Organ Transplantation
Presentation on Organ TransplantationSoumen Kanjilal
 
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...WSACS
 
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...International Fluid Academy
 
Dialytic management of acute kidney injury
Dialytic management of acute kidney injuryDialytic management of acute kidney injury
Dialytic management of acute kidney injuryد.محمود نجيب
 
Delayed graft function: Kidney Transplant
Delayed graft function: Kidney TransplantDelayed graft function: Kidney Transplant
Delayed graft function: Kidney TransplantAhad Lodhi
 
Blood Conservation
Blood ConservationBlood Conservation
Blood Conservationpprashant00
 

Similaire à Kidney Preservation: method and trends (20)

Renal Replacement therapy in the ICU
Renal Replacement therapy in the ICU Renal Replacement therapy in the ICU
Renal Replacement therapy in the ICU
 
liver transplantation
liver transplantation liver transplantation
liver transplantation
 
November2011webinar
November2011webinarNovember2011webinar
November2011webinar
 
Rrt in icu dr said khamis zagazig april 2018 latest
Rrt in  icu dr said khamis zagazig april 2018 latestRrt in  icu dr said khamis zagazig april 2018 latest
Rrt in icu dr said khamis zagazig april 2018 latest
 
Anesthetic considerations for kidney transplant in an adult
Anesthetic considerations for kidney transplant in an adult Anesthetic considerations for kidney transplant in an adult
Anesthetic considerations for kidney transplant in an adult
 
RRT
RRTRRT
RRT
 
5. perioperative assessment of Hemodialysis patients. Dr. Ahmed Kamal.pptx
5. perioperative assessment of Hemodialysis patients. Dr. Ahmed Kamal.pptx5. perioperative assessment of Hemodialysis patients. Dr. Ahmed Kamal.pptx
5. perioperative assessment of Hemodialysis patients. Dr. Ahmed Kamal.pptx
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
 
Anaesthesia for liver transplantation
Anaesthesia for liver transplantationAnaesthesia for liver transplantation
Anaesthesia for liver transplantation
 
Renal transplantation -friday_prof_ayman refaei
Renal transplantation -friday_prof_ayman refaeiRenal transplantation -friday_prof_ayman refaei
Renal transplantation -friday_prof_ayman refaei
 
Anaesthesia for renal transplant
Anaesthesia for renal transplantAnaesthesia for renal transplant
Anaesthesia for renal transplant
 
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdfANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
 
Prevention of aki on icu
Prevention of aki on icuPrevention of aki on icu
Prevention of aki on icu
 
Marcelo Cypel - Canada - Tuesday 29 - Organ Donor Care. New Alternatives
Marcelo Cypel  - Canada - Tuesday 29 - Organ Donor Care. New AlternativesMarcelo Cypel  - Canada - Tuesday 29 - Organ Donor Care. New Alternatives
Marcelo Cypel - Canada - Tuesday 29 - Organ Donor Care. New Alternatives
 
Presentation on Organ Transplantation
Presentation on Organ TransplantationPresentation on Organ Transplantation
Presentation on Organ Transplantation
 
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
 
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
Monitoring macro and microcirculation (Joel Starkopf WSACS session ESA 2018 #...
 
Dialytic management of acute kidney injury
Dialytic management of acute kidney injuryDialytic management of acute kidney injury
Dialytic management of acute kidney injury
 
Delayed graft function: Kidney Transplant
Delayed graft function: Kidney TransplantDelayed graft function: Kidney Transplant
Delayed graft function: Kidney Transplant
 
Blood Conservation
Blood ConservationBlood Conservation
Blood Conservation
 

Dernier

High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)Mohamed Rizk Khodair
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxLikeways
 
World-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxWorld-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxsumanchaulagain3
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Microbiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxMicrobiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxkitati1
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).kishan singh tomar
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?Ryan Addison
 

Dernier (20)

High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
 
World-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxWorld-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptx
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Microbiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxMicrobiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptx
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?
 
Cone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptxCone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptx
 

Kidney Preservation: method and trends

  • 1. JOURNAL REVIEW KIDNEY PRESERVATION: METHODS AND TRENDS Keith Tsui, Daniel Wong, Kenneth Kwok, Patrick Tsai, Bernard Yung
  • 2. Outline • History of kidney preservation • Static Cold Storage (SCS) • Hypothermic Machine Perfusion (HMP) • SCS vs HMC • Conclusion
  • 3. Organ transplantation • Major advances in latter half of the 20th century • Only curative treatment for end-stage organ failure in many cases
  • 4. Deceased Donor Types • Donation after brain death (DBD) • Standard criteria donors (SCD)  Under 50 years old • Expanded criteria donors (ECD)  Over 60 years old OR  Aged 50-59 years old with at least 2 of the following: • Hypertension • Cerebrovascular cause of brain death • Pre-retrieval serum creatinine level > 1.5 mg/dL (132.6umol/L) • Donation after circulatory death (DCD) Metzger RA, Delmonico FL, Feng S, et al. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003
  • 5. Kidney transplant 1. Retrieving the organ from donor 2. Preserving the kidney 3. Implantation in the recipient
  • 6. Why organ preservation?  Preservation buys “time”  Good organ preservation is a major determinant of graft outcome after re-vascularisation Organ Preservation: Current Concepts and New Strategies for the Next Decade; Transfus Med Hemother. Apr 2011
  • 7. Methods of Organ Preservation • Static Cold Storage (SCS) • Dynamic Preservation • Hypothermic machine perfusion (HMP) • Normothermic machine perfusion • Oxygen persufflation
  • 9. Kidney Preservation Warm ischaemic time in donor Cold ischaemic time Warm ischaemic time in recipient
  • 10. Static Cold Storage (SCS) • First used in 1969, with Collins solution • Mainstay method of preservation for kidneys, livers, and others • Tackle problems during cold ischaemic time preservation possible up to 24 hours or longer “Preservation Solutions for Static Cold Storage of Kidney Allografts: A Systematic Review and Meta-Analysis”, American Journal of Transplantation 2012
  • 11. Static Cold Storage (SCS) •Wash with sterile hypothermic preservation solution • Kidney core temperature  0-4oC • Store in ice water Image source: St. Louis Public Radio
  • 12. In ischaemic condition… No Oxygen Intracellular ATP depletion Impaired Na/K ATPase Passive inflow of Na Water influx Cell swelling and damage Anaerobic respiration Lactic acid builds up Activate intracellular enzymes Lysosomal damage Na/Ca exchange Build up of intracellular Ca “Kidney Preservation: Review of Present and Future Perspective”, Transplantation Proceedings 2013
  • 13. Principles used in SCS 1. Hypothermia decrease kinetics of metabolic activities 2. Specific solutions preserve intracellular environment in the absence of Na+/K+ pumps 3. High osmolarity in solutions reduce cell swelling 4. Remove free radicals “Preservation methods for kidney and liver”, Organogenesis 2009
  • 14. Advantages of SCS • Cheaper - 1L UW solution: £116 (~HKD$1500) - LifePort kidney transporter x1: £10,700 (~HKD$135,000) + other costs Nice Guideline 2010 • Technically easier
  • 15. Disadvantages of SCS • No standardised parameters to evaluate: 1. organ viability 2. ischaemic damage  predictors of post-transplant outcomes
  • 17. EC, Eurocollins UW, University of Wisconsin HTK, histidine-tryptophan-ketoglutarate;
  • 18. Euro-Collins solution •Phosphate - as pH buffer •Glucose - as osmotic agent Preservation methods for kidney and liver; Organogenesis. 2009
  • 19. EC, Eurocollins UW, University of Wisconsin HTK, histidine-tryptophan-ketoglutarate;
  • 20. UW solution • Cell impermeant agents (lactobionic acid, raffinose, hydroxyethyl starch) • prevent the cells from swelling during cold ischemic storage • Glutathione and adenosine • stimulate recovery of normal metabolism upon reperfusion Organ Preservation; Annual Review of Medicine; Vol. 46
  • 21. EC, Eurocollins UW, University of Wisconsin HTK, histidine-tryptophan-ketoglutarate;
  • 22. Histidine-Tryptophane-Ketoglutarate (HTK)** • Histidine – as potent buffer •Tryptophan – as membrane stabilizer and anti-oxidant • Ketoglutarate – improve ATP production during reperfusion
  • 24. Original method of preservation • Replaced by SCS due to development of preservation solutions as a cheaper alternative Photo from Kidney Transplant: Principles and Practice
  • 25. Resurgence of interest • Changes in donor pool • US • ECDs increased 36% between 1999 and 2005 • 22% of kidneys transplanted in 2009 • DCD accounted for 13% of donors United States Organ Transplantation OPTN & SRTR Annual Data Report 2010 • UK • DCD kidneys in UK increased from 3% to 32% between 2000 and 2009 Summers DM, Johnson RJ, Allen J, et al. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study. Lancet 2010
  • 26. Machine Perfusion • Solutions • Eurocollins solution, UW solution, HTK solution, hyperosmolar citrate solution, Celsior solution, Institute Georges Lopez-1 solution • Hypothermic perfusion • Waters MOX DCM-100 • UP-100 • LifePort Kidney Transporter • Kidney assist • Normothermic perfusion • POPS system
  • 27. Basic design of a perfusion machine Waters MOX DCM-100
  • 28. Hypothermic perfusion machine Normothermic perfusion machine
  • 30. Cost effective? •LifePort Kidney transporter • Cost savings = $86 750 per life-year gained • Cost utility ratio was minus $496 223 per quality-adjusted life-year (QALY) gained Cost-Effectiveness of Hypothermic Machine Preservation Versus Static Cold Storage in Renal Transplantation; H Groen; American journal of transplantation 2012
  • 31. Not inferior or even better? • No difference in primary non-function, acute rejection, long-term renal function or patient survival Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes; J. M. O’Callaghan; Transplantation 2012 • Decreased rates of DGF To Pump or Not to Pump: A Comparison of Machine Perfusion vs Cold Storage for Deceased Donor Kidney Transplantation; Robert M Cannon; J Am Coll Surg 2013
  • 32. Static Cold Storage vs Hypothermic Machine Perfusion
  • 33. Study end points • Delayed graft function (DGF) • Requirement for dialysis during the first week after transplantation • Primary Non-Function (PNF) • Permanent lack of function of allograft from the time of transplantation • Graft survival/ failure • Censored at the time of death
  • 34. SCS vs HMP • International randomized controlled trial with 336 donors
  • 35. Results • Delayed graft function • significantly reduced risk of DGF (adjusted odds ratio, 0.57, p=0.01) • Primary Non-Function • More than 2 times higher in SCS but not significant (4.8% vs 2.1%, p=0.08) • Graft survival/ failure • Three-year allograft survival superior in MP group (91% vs 87%, hazard ratio, 0.60 p=0.04)
  • 36. ECD Subgroup analysis • Expanded criteria donors (94 out of 336) had a significant three-year graft survival (86% vs 76%; adjusted hazard ratio, 0.38; p=0.01) • Another RCT with 91 ECDs had similar results: • significantly reduced the risk of DGF (29.7% vs 22%, OR 0.460, P = 0.047). • incidence of nonfunction in the CS group (12%) was four times higher than in the MP group (3%) (P = 0.04). • One-year graft survival was significantly higher in machine perfused kidneys (92.3% vs. 80.2%, P = 0.02). Treckmann J, Moers C, Smits J, et al. Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int
  • 37. Donation after Circulatory Death (DCD) • Donors not declared brain death • Ethical concerns “Hypothermic machine perfusion was associated with a reduced risk of DGF and better early graft function up to 1 month after transplantation. Routine preservation of DCD kidneys by hypothermic machine perfusion is therefore advisable.”
  • 38. Future of HMP • Renal resistance indexes to evaluate marginal organs Jochmans I, Moers C, Smits J, et al. The prognostic value of renal resistance during hypothermic machine perfusion of deceased donor kidneys. Am J Transplant 2011 • Biomarkers to predict delayed graft function Moers C, Varnav OC, van Heurn E, et al. The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome. Transplantation 2010 • Other methods: normothermic perfusion, oxygen persufflation Matsuno N, Konno O, Mejit A, et al. Application of machine perfusion preservation as a viability test for marginal kidney graft. Transplantation 2006
  • 39. Take Home Messages • Only possible improvement in SCS is new solutions • HMP is the way to go? • Rapidly advancing field • Possible additional benefit of HMP in the future • Not inferior to SCS • Significant advantage for ECD • Look out for other developing methods • HMP in other organs?
  • 40. Special Thanks Supervisor: Dr. G Leung Acknowledgement: Dr. MK Yiu
  • 42. Which one better? Primary end point = Delayed Graft Function (DGF)
  • 43. Which one better? Lynch RJ, et al. AJT 2008; 8:567-73
  • 44. Post-transplant kidney graft survival Living Donor: HTK n=475 UW n=475 Deceased donor: HTK n=317 UW n=317 Lynch RJ, et al. AJT 2008; 8:567-73
  • 45. Lynch RJ, et al. AJT 2008; 8:567-73